"They did a completely separate phase 3 trial on over 500 subjects and learnt something new. That's what it was for. To extend knowledge of how the material works."
To learn something new is never the main aim of a phase 3 clinical trial. It may be the silver lining when the trial doesn't achieve its main aim - to confirm a hypothesis developed in earlier phases.
USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse, page-38
-
- There are more pages in this discussion • 274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.196M | 3.555M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 7057 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 17318 | 9 |
View Market Depth
| Last trade - 13.30pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |